SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

SXTP

60 Degrees Pharmaceuticals Inc.
NASDAQHealth Care

Latest close: 0.86 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell◆Adverse 8-K filing●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Oct 6, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Sep 14, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  3. Sep 8, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record19515 flagged findings
Reported transactions (Form 4)58since Jul 12, 2023 · and 20 other holdings
Corporate events (8-K)18since Jul 17, 2023

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 195)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 6, 268-K ↗Current report · Communication to the market · Other events
  • Sep 14, 268-K ↗Current report · Other events
  • Sep 8, 268-K ↗Current report · Communication to the market
  • Aug 14, 2610-Q ↗Quarterly report
  • Aug 14, 26S-3 ↗Securities offering
  • Aug 6, 268-K ↗Current report · Shareholder vote results
  • Aug 5, 26SCHEDULE 13G ↗Passive stake · Lind Global Fund III LP · 5.5% · event on Jul 31, 26
  • Aug 4, 268-K ↗Current report · Entered a material agreement
  • Jul 29, 26Form 3 ↗Insider transaction
  • Jul 29, 26SCHEDULE 13G ↗Passive stake · Knight Therapeutics Inc. · 19.9% · event on Jul 22, 26
  • Jul 20, 268-K ↗Current report · Communication to the market
  • Jul 9, 268-K ↗Current report · Other events
  • Jul 2, 26DEF 14A ↗Shareholder meeting and votes
  • Jun 15, 26Form 4 ↗Insider transaction
  • Jun 8, 26PRE 14A ↗Shareholder meeting and votes
  • Jun 3, 268-K ↗Current report · Other events
  • May 19, 26Form 3 ↗Insider transaction
  • May 18, 268-K ↗Current report · A senior executive left or was appointed
  • May 15, 26SCHEDULE 13G/A ↗Passive stake · CVI Investments, Inc. · 7.0% · event on Mar 31, 26 · amendment
  • May 15, 2610-Q ↗Quarterly report
  • May 15, 26SCHEDULE 13G/A ↗Passive stake · amendment
  • May 13, 26SCHEDULE 13G/A ↗Passive stake · Mitchell P. Kopin · 9.1% · event on Mar 31, 26 · amendment
  • Mar 30, 2610-K ↗Annual report
  • Mar 20, 268-K ↗Current report · Other events
  • Mar 13, 26424B5 ↗Securities offering

195 filings on record, the oldest from Nov 14, 22.

Listing the 25 most recent filings of the 195 on record.

8-Ks, explained

Stress3Structure14Governance1
  • Aug 4, 26StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • May 18, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Jan 23, 26StressListing notice (8-K 3.01)+1 more in the same filing · the filing reports the decision to delist8-K 3.01 ↗
  • Structure5 material agreements entered2024 – 2025show all 5hide
    • Sep 5, 25StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
    • Jul 18, 25StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
    • Feb 6, 25StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
    • Jan 30, 25StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
    • Sep 6, 24StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Feb 28, 24StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Feb 20, 24StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Feb 2, 24StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Nov 3, 23StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Jul 17, 23StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • Knight Therapeutics Inc.19.9%Jul 22, 26SCHEDULE 13G ↗
  • Mitchell P. Kopin9.1%Mar 31, 26SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 3 earlier filings
  • CVI Investments, Inc.7.0%Mar 31, 26SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
  • Lind Global Fund III LP5.5%Jul 31, 26SCHEDULE 13G ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
  • Armistice Capital, LLC5.0%Mar 31, 25SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
show 2 more holdershide
  • Orca Capital AG4.9%Jul 15, 25SCHEDULE 13G/A ↗1 earlier filing
  • Ayrton Capital LLC4.1%Sep 30, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Jun 12, 26Buy$10KGEOFFREY S DOWPresident and CEO↗
  • Dec 15, 25Buy$8KGEOFFREY S DOWPresident and CEO↗
  • Dec 11, 25Buy$3KGEOFFREY S DOWPresident and CEO↗
  • Dec 10, 25Buy$9KGEOFFREY S DOWPresident and CEO↗
  • Jun 3, 25Buy$9KCHERYL XU↗
  • Jun 3, 25Buy$6KCHERYL XU↗
  • Dec 16, 24Buy$3KCHERYL XU↗
  • Dec 13, 24Buy$2KCHERYL XU↗
  • Dec 13, 24Buy$2KCHERYL XU↗
  • Dec 13, 24Buy$2KCHERYL XU↗
  • Dec 13, 24Buy$2KCHERYL XU↗
  • Dec 12, 24Buy$5KCHERYL XU↗

There are 10 more transactions in this stretch.

Stock compensation, tax and giftsshow the 16 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Sep 12, 25Compensation$10KGEOFFREY S DOWPresident and CEO↗
  • Jun 9, 25Compensation$13KGEOFFREY S DOWPresident and CEO↗
  • Jan 17, 25Compensationamount n/aKristen LandonChief Operating Officer↗
  • Jan 17, 25Compensationamount n/aTYRONE MILLERCFO↗
  • Jan 17, 25Compensationamount n/aGEOFFREY S DOWPresident and CEO↗
  • May 16, 24Compensation$892Charles W Allen↗
  • May 16, 24Compensation$4KGEOFFREY S DOWPresident and CEO↗
  • May 16, 24Compensation$892PAUL FIELD↗
  • May 16, 24Compensation$3KTYRONE MILLERCFO↗
  • May 16, 24Compensation$892STEPHEN TOOVEY↗
  • May 16, 24Compensation$446CHERYL XU↗
  • Apr 12, 24Compensation$18KGEOFFREY S DOWPresident and CEO↗
  • Apr 12, 24Compensation$16KTYRONE MILLERCFO↗
  • Feb 1, 24Compensationamount n/aCHERYL XU↗
  • Jul 28, 23Other$216KKnight Therapeutics Inc↗
  • Jul 28, 23Otheramount n/aKnight Therapeutics Inc↗

The full record holds 38 transactions and goes back to Jul 11, 23.

Its sector and its market

60 Degrees Pharmaceuticals Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From 60 Degrees Pharmaceuticals Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow 60 Degrees Pharmaceuticals Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
Series with incidents in the period; the chart shows what could be kept.
SEC records
195 documents on file, from Nov 14, 2022 to Oct 6, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.